SynthesisBreast (Edinburgh, Scotland)2022

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology.

Federica Miglietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.